Cargando…

Natural Killer Cell Line NK-92-Mediated Damage of Medically Important Fungi

Invasive fungal disease (IFD) in hematopoietic stem cell transplantation is associated with high morbidity and mortality. As the antifungal host response determines risk and outcome of IFD, there is growing interest in adoptive immunotherapy using T cells or natural killer (NK) cells. Although the N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Stanislaw, Luckowitsch, Marie, Hogardt, Michael, Lehrnbecher, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922546/ https://www.ncbi.nlm.nih.gov/pubmed/33671240 http://dx.doi.org/10.3390/jof7020144

Ejemplares similares

Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
por: Klingemann, Hans, et al.
Publicado: (2016)

Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
por: Panwong, Suthida, et al.
Publicado: (2021)

Aspergillus fumigatus responds to natural killer (NK) cells with upregulation of stress related genes and inhibits the immunoregulatory function of NK cells
por: Schneider, Andreas, et al.
Publicado: (2016)

Natural Killer Cells in Antifungal Immunity
por: Schmidt, Stanislaw, et al.
Publicado: (2017)

Distinct Effects of Immunosuppressive Drugs on the Anti-Aspergillus Activity of Human Natural Killer Cells
por: Schmidt, Stanislaw, et al.
Publicado: (2019)

Na(+)/H(+)-exchanger 1 Enhances Antitumor Activity of Engineered NK-92 Natural Killer Cells
por: Gong, Yao-Yu, et al.
Publicado: (2022)

Natural killer cells as a therapeutic tool for infectious diseases – current status and future perspectives
por: Schmidt, Stanislaw, et al.
Publicado: (2018)

Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
por: Zhang, Jianguang, et al.
Publicado: (2019)

NK Cells and Their Role in Invasive Mold Infection
por: Schmidt, Stanislaw, et al.
Publicado: (2017)

Immunosuppressive Compounds Affect the Fungal Growth and Viability of Defined Aspergillus Species
por: Schmidt, Stanislaw, et al.
Publicado: (2019)

Central Nervous System Mold Infections in Children with Hematological Malignancies: Advances in Diagnosis and Treatment
por: Luckowitsch, Marie, et al.
Publicado: (2021)

Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model
por: Zhu, Liya, et al.
Publicado: (2017)

Efficient delivery of oncolytic enterovirus by carrier cell line NK-92
por: Podshivalova, Elizaveta Sergeevna, et al.
Publicado: (2021)

Optimizing NK-92 serial killers: gamma irradiation, CD95/Fas-ligation, and NK or LAK attack limit cytotoxic efficacy
por: Navarrete-Galvan, Lydia, et al.
Publicado: (2022)

An integrated workflow for phosphopeptide identification in natural killer cells (NK-92MI) and their targets (MDA-MB-231) during immunological synapse formation
por: Perez-Hernandez, Daniel, et al.
Publicado: (2023)

Proliferation of Highly Cytotoxic Human Natural Killer Cells by OX40L Armed NK-92 With Secretory Neoleukin-2/15 for Cancer Immunotherapy
por: Guo, Meng, et al.
Publicado: (2021)

Natural Born Killers: NK Cells in Cancer Therapy
por: Franks, S. Elizabeth, et al.
Publicado: (2020)

Interferon Gamma Induces Changes in Natural Killer (NK) Cell Ligand Expression and Alters NK Cell-Mediated Lysis of Pediatric Cancer Cell Lines
por: Aquino-López, Arianexys, et al.
Publicado: (2017)

Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells
por: Villalba, Martin, et al.
Publicado: (2020)

Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells
por: Zhang, Ben-ning, et al.
Publicado: (1997)

Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
por: Smyth, Mark J., et al.
Publicado: (2000)

The Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells
por: Houh, Youn Kyung, et al.
Publicado: (2017)

What Fuels Natural Killers? Metabolism and NK Cell Responses
por: Gardiner, Clair M., et al.
Publicado: (2017)

Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy
por: Murugan, Dhanashree, et al.
Publicado: (2022)

Pyocyanin induces NK92 cell apoptosis via mitochondrial damage and elevated intracellular Ca(2+)
por: Li, Ting, et al.
Publicado: (2018)

The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization
por: Brown, Bruce K., et al.
Publicado: (2012)

Natural killer (NK) activity in the spleen of patients with Hodgkin's disease and controls.
por: Al Sam, S., et al.
Publicado: (1982)

Selection and expansion of natural killer cells for NK cell-based immunotherapy
por: Becker, Petra S. A., et al.
Publicado: (2016)

Sialylation of Human Natural Killer (NK) Cells Is Regulated by IL-2
por: Rosenstock, Philip, et al.
Publicado: (2020)

Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy
por: Islam, Rasa, et al.
Publicado: (2021)

Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T Cells Poised for Rapid Effector Function
por: Stetson, Daniel B., et al.
Publicado: (2003)

Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma
por: Kwong, Sara, et al.
Publicado: (2020)

Natural Killer (NK) Cell–mediated Cytotoxicity: Differential Use of TRAIL and Fas Ligand by Immature and Mature Primary Human NK Cells
por: Zamai, Loris, et al.
Publicado: (1998)

Recruitment and Activation of Natural Killer (Nk) Cells in Vivo Determined by the Target Cell Phenotype: An Adaptive Component of Nk Cell–Mediated Responses
por: Glas, Rickard, et al.
Publicado: (2000)

Persistence of Natural Killer (NK) cell lymphocytosis with hyposplenism without development of leukaemia
por: Khan, Sujoy, et al.
Publicado: (2005)

First do no harm: uterine natural killer (NK) cells in assisted reproduction
por: Moffett, Ashley, et al.
Publicado: (2015)

Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
por: Sun, Cheng, et al.
Publicado: (2015)

Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer
por: Nersesian, Sarah, et al.
Publicado: (2019)

Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
por: Chen, Ziqing, et al.
Publicado: (2019)

Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies
por: Carrega, Paolo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_771av1950fsdk5iiclik3tv1ah